Stay updated on Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.

Latest updates to the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed information about a Phase II trial studying nivolumab for preventing colon adenomas in patients with Lynch syndrome, while adding new collaborators and a revision update.SummaryDifference51%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.